Adverse pathophysiological influence of early testosterone therapy on the testes of boys with higher grade sex chromosome aneuploidies (HGAs): a retrospective, cross-sectional study
- PMID: 33098655
- PMCID: PMC8195784
- DOI: 10.1007/s40618-020-01452-w
Adverse pathophysiological influence of early testosterone therapy on the testes of boys with higher grade sex chromosome aneuploidies (HGAs): a retrospective, cross-sectional study
Abstract
Purpose: Higher grade aneuploidies (HGAs) of the male sex chromosomes are a rare genetic group of pathologies caused by nondisjunction meiotic events. The aim of this study was to evaluate the impact of early androgenic therapy on the testicular secretory hormone profile, and the pathophysiological implications.
Patients and methods: In this cross-sectional study, 18 HGA subjects aged 6-8 years were recruited. They were divided into two groups, based on whether or not they had previously undergone testosterone therapy (group 1: 11 untreated subjects; group 2: 7 treated subjects). Serum FSH, LH, testosterone (T), inhibin B (INHB) and anti-Müllerian hormone (AMH) were determined, and auxological parameters were assessed. Five group 1 patients and four group 2 patients were treated with hCG (human chorionic gonadotropin) for inguinal cryptorchidism; their hormone profile and auxological parameters were assessed both pre- and post-hCG treatment.
Results: Group 1 subjects showed significantly higher testicular volume and higher levels of AMH and INHB (p < 0.0001). Subjects who had undergone hCG therapy showed a significantly higher testicular volume, penis length (respectively, p = 0.008 and p = 0.0005 for group 1 and p = 0.04 and p = 0.001 for group 2) and T (p = 0.005 for group 1 and p = 0.004 for group 2).
Conclusions: HGA patients undergoing early testosterone therapy show an earlier and persistent suppression of testicular secretory function. At this age, the testes are still responsive to stimulation with hCG. The selection of patients to be treated must be accompanied by a thorough clinical and hormonal evaluation.
Keywords: 48,XXXY; 48,XXYY; 49,XXXXY; Cryptorchidism; Leydig cells; Sertoli cells.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Serum inhibin B, FSH, LH and testosterone levels before and after human chorionic gonadotropin stimulation in prepubertal boys with cryptorchidism.Eur J Endocrinol. 2002 Jul;147(1):95-101. doi: 10.1530/eje.0.1470095. Eur J Endocrinol. 2002. PMID: 12088925 Clinical Trial.
-
Distinguishing between hidden testes and anorchia: the role of endocrine evaluation in infancy and childhood.Eur J Endocrinol. 2020 Jul;183(1):107-117. doi: 10.1530/EJE-20-0041. Eur J Endocrinol. 2020. PMID: 32422605
-
Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.J Clin Endocrinol Metab. 2005 Feb;90(2):724-8. doi: 10.1210/jc.2004-0542. Epub 2004 Nov 9. J Clin Endocrinol Metab. 2005. PMID: 15536161
-
Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.Mol Cell Endocrinol. 2003 Dec 15;211(1-2):51-4. doi: 10.1016/j.mce.2003.09.020. Mol Cell Endocrinol. 2003. PMID: 14656476 Review.
-
Sertoli cell markers in the diagnosis of paediatric male hypogonadism.J Pediatr Endocrinol Metab. 2012;25(1-2):3-11. doi: 10.1515/jpem-2011-0453. J Pediatr Endocrinol Metab. 2012. PMID: 22570945 Review.
Cited by
-
From Klinefelter Syndrome to High Grade Aneuploidies: Expanding the Gene-dosage Effect of Supernumerary X Chromosomes.J Clin Endocrinol Metab. 2024 Jul 12;109(8):e1564-e1573. doi: 10.1210/clinem/dgad730. J Clin Endocrinol Metab. 2024. PMID: 38193351 Free PMC article.
-
Clinical, Cognitive and Neurodevelopmental Profile in Tetrasomies and Pentasomies: A Systematic Review.Children (Basel). 2022 Nov 9;9(11):1719. doi: 10.3390/children9111719. Children (Basel). 2022. PMID: 36360447 Free PMC article. Review.
-
Recent advancement in the treatment of boys and adolescents with hypogonadism.Ther Adv Endocrinol Metab. 2022 Jan 5;13:20420188211065660. doi: 10.1177/20420188211065660. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35035874 Free PMC article. Review.
References
-
- Sorensen K, Nielsen J, Jacobsen P, Rolle T. The 48, XXYY syndrome. J Ment Defic Res. 1978;22:197–205. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources